Back to search

Article

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5

2022-05-26

Abstract excerpt

SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have surged dramatically to become dominant in the United States and South Africa, respectively 1,2 . These novel subvariants carrying additional mutations in their spike proteins raise concerns that they may further evade neutralizing antibodies, thereby further compromising the efficacy of COVID-19 vaccines and therapeutic monoclonals. We now report findings f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c415895c-1bd0-52aa-99f0-8e44a5ea5cb8
DOI
10.1101/2022.05.26.493517
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5DOI 10.1101/2022.05.26.493517
Select a neighboring publication to make it the new centre.